Sources of Neonatal Medicine
Lin F.a· Xu J.-X.a· Wu Y.-H.a· Chen Z.-K.b· Chen M.-T.a· Ma Y.-B.c· Li J.-D.c· Yang L.-Y.daPrecision Medical Lab Center, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou, China
bSchool of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, China
cDepartment of Neonatology, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou, China
dPrecision Medical Lab Center, People’s Hospital of Yangjiang, Yangjiang, China
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: September 07, 2022
Accepted: January 31, 2023
Published online: April 11, 2023
Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
AbstractIntroduction: Neonatal hyperbilirubinemia is common and remains a clinical concern in China. Since neonatal hyperbilirubinemia is linked to genetic factors, we aimed to identify the gene variants of the red blood cell membrane (RBCM) and evaluate the clinical risk factors in Chinese neonates with hyperbilirubinemia. Methods: 117 hyperbilirubinemia neonates (33 cases of moderate hyperbilirubinemia and 84 cases of severe hyperbilirubinemia) and 49 controls with normal bilirubin levels were selected as our study subjects. A customized 22-gene panel with next-generation sequencing (NGS) was designed to characterize genetic variations among the neonates. Sanger sequencing was used to verify the accuracy of the NGS. The clinical risk factors and potential effects of genetic variations in neonates with hyperbilirubinemia were subsequently assessed. Results: After data filtering, suspected pathogenic variants of UGT1A1, SLCCO1B1, and RBCM-associated gene were identified in neonates, the combined numbers of RBCM-associated gene variants were found to have differences between the hyperbilirubinemia group and the controls (p = 0.008), they were also different between severe hyperbilirubinemia and moderate hyperbilirubinemia (p = 0.008), and were correlated with an increased risk of hyperbilirubinemia (odds ratio = 9.644, p = 0.006). The UGT1A1-rs4148323 variant in neonates with hyperbilirubinemia was significantly increased as compared with the controls (p < 0.001). However, there was no statistical difference for the SLCO1B1-rs2306283 variant between the hyperbilirubinemia group and the controls. In addition, breastfeeding contributed to an increased risk of hyperbilirubinemia. Conclusion: Our study highlights that the RBCM-related gene variants are an underestimated risk factor, which may play an important role in developing hyperbilirubinemia in Chinese newborns.
© 2023 S. Karger AG, Basel
References Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia: a global perspective perspective. Lancet Child Adolesc Health. 2018;2(8):610–20. Christensen RD, Yaish HM, Gallagher PG. A pediatrician’s practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics. 2015;135(6):1107–14. Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis-2021 update. J Clin Lab Anal. 2021;35(12):e24034. Andolfo I, Russo R, Gambale A, Iolascon A. New insights on hereditary erythrocyte membrane defects. Haematologica. 2016;101(11):1284–94. Warang P, Kedar P. Hereditary elliptocytosis: a rare red cell membrane disorder. Indian J Hematol Blood Transfus. 2018;34(4):754–5. Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders. Br J Haematol. 2019;187(1):13–24. Huang MJ, Lin YC, Liu K, Chang PF, Huang CS. Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia. Pediatr Neonatol. 2020;61(5):506–12. Editorial Board of Chinese Journal of Pediatrics; Subspecialty Group of Neonatology, The Society of Pediatrics, Chinese Medical Association. Expert consensus for diagnosis and treatment of neonatal hyperbilirubinemia. Zhonghua Er Ke Za Zhi. 2014;52(10):745–8. (in Chinese). Yang H, Wang Q, Zheng L, Lin M, Zheng XB, Lin F, et al. Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of Chinese descent. PLoS One. 2015;10(7):e0132034. Yang H, Wang Q, Zheng L, Zheng XB, Lin M, Zhan XF, et al. Clinical significance of UGT1A1 genetic analysis in Chinese neonates with severe hyperbilirubinemia. Pediatr Neonatol. 2016;57(4):310–7. Li YP, Wu T, Chen L, Zhu YX. Associations between G6PD, OATP1B1 and BLVRA variants and susceptibility to neonatal hyperbilirubinaemia in a Chinese Han population. J Paediatr Child Health. 2019;55(9):1077–83. Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, et al. Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population. J Hum Genet. 2011;56(7):503–7. Cheng CF, Lin YJ, Lin MC, Liang WM, Chen CC, Chen CH, et al. Genetic risk score constructed from common genetic variants is associated with cardiovascular disease risk in type 2 diabetes mellitus. J Gene Med. 2021;23(2):e3305. Xu JX, Lin F, Chen ZK, Luo ZY, Zhan XF, Wu JR, et al. Co-inheritance of G6PD deficiency and 211 G to a variation of UGT1A1 in neonates with hyperbilirubinemia in eastern Guangdong. BMC Pediatr. 2021;21(1):564. Lin F, Xu JX, Wu YH, Ma YB, Yang LY. Clinical features and genetic variations of severe neonatal hyperbilirubinemia: five case reports. World J Clin Cases. 2022;10(20):6999–7005. Wang X, Liu A, Huang M, Shen N, Lu YJ, Hu Q. Hereditary elliptocytosis with variable expression and incomplete penetrance in a Chinese family. Br J Haematol. 2019;186(5):e159–62. Mei H, Dong X, Wu B, Wang H, Lu Y, Hu L, et al. Clinical and genetic etiologies of neonatal unconjugated hyperbilirubinemia in the China neonatal genomes project. J Pediatr. 2022;243:53–60.e9. Cheng SW, Chiu YW, Weng YH. Etiological analyses of marked neonatal hyperbilirubinemia in a single institution in Taiwan. Chang Gung Med J. 2012;35(2):148–54. Peng GX, Yang WR, Zhao X, Jin LP, Zhang L, Zhou K, et al. The characteristic of hereditary spherocytosis related gene mutation in 37 Chinese hereditary spherocytisis patients. Zhonghua Xue Ye Xue Za Zhi. 2018;39(11):898–903. Ma S, Qin J, Wei A, Li X, Qin Y, Liao L, et al. Novel compound heterozygous SPTA1 mutations in a patient with hereditary elliptocytosis SPTA1 mutations in a patient with hereditary elliptocytosis. Mol Med Rep. 2018;17(4):5903–11. Liu C, Eun HS, Nah H, Lee ST, Choi JR, Kim HO. Newborn hereditary elliptocytosis confirmed by familial genetic testing. Int J Lab Hematol. 2020;42(1):e20–2. Clark M. Clinical update: understanding jaundice in the breastfed infant. Community Pract. 2013;86(6):42–4; quiz 45. Soldi A, Tonetto P, Chiale F, Varalda A, Peila C, Sabatino G, et al. Hyperbilirubinemia and management of breastfeeding. J Biol Regul Homeost Agents. 2012;26(3 Suppl l):25–9. Najib KS, Saki F, Hemmati F, Inaloo S. Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of Iran (fars province). Iran Red Crescent Med J. 2013;15(3):260–3. Brits H, Adendorff J, Huisamen D, Beukes D, Botha K, Herbst H, et al. The prevalence of neonatal jaundice and risk factors in healthy term neonates at National District Hospital in Bloemfontein. Afr J Prim Health Care Fam Med. 2018;10(1):e1–6. Article / Publication DetailsFirst-Page Preview
Received: September 07, 2022
Accepted: January 31, 2023
Published online: April 11, 2023
Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Comments (0)